Across TCGA pan-cancer cohorts, D2HGDH mass-spec protein is linked to patient survival in 5 of 34 cancer types, making it a survival-associated D2HGDH data layer compared with 26 for mass-spec protein and 4 for mutation status.
The strongest signal is observed in colon adenocarcinoma (COAD), where higher D2HGDH mass-spec protein is associated with better disease-free survival. In most high-consensus cancer types, elevated D2HGDH expression acts as an unfavorable survival marker, although some lineages such as COAD and CCRCC show a favorable association.
COAD, HNSC, and CCRCC are the cancer types where D2HGDH mass-spec protein most reproducibly stratifies survival.